Cosmetics Toiletries, March 17 2020
The FDA’s latest sunscreen scrutiny is focused on the test protocol for the Maximal Usage Trial study (MUsT). This human pharmacokinetic test measures the amount of absorption of a drug into the body. What else might it tell us?
In a January 2020 meeting at the New York Chapter of Society of Cosmetic Chemists (NYSCC), Howard Epstein, Ph.D., director of technical services for EMD Performance Materials in Philadelphia, provided an update regarding the U.S. Food and Drug Administration’s (FDA’s) proposed changes to Sunscreen Innovation Act, introduced in February 2019.
Beatrice Wihlander 14 April 2025 study has demonstrated how human organ-on-a-chip technologies have the potential…
Cassandra Stern 23 April 2025 “The use of product content optimization (PCO) is critical for…
Odile Monod 17 April 2025 Following its successful ventures in skin microbiome research, Korean cosmetic manufacturing…